MEDISCRIPTA
ActiveSummary
MEDISCRIPTA has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€48,573) and a net result of -€17,738. Its solvency ranks better than 5% of 16666 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability33▲+13
Solvency21▼-1
Growth58
Track record82
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.25 against 0.4 in 2024; short-term debt: 5.2% and cash: 0.6% of total assets), and equity is negative.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
-4.5%
Return on assets
-1.6%
Age of the figures
9 mo
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
2425
2024 to 2025 · latest year -€48,573
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-07-2026, 4 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
4 d early
2024
24 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 2 accounts on average 14 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
26-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed Is the workforce growing, and do people stay?Employer check
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
-€48,573▼ 57.5%
2024 · -€30,836
Total assets
€1.1m▲ 0.2%
2024 · €1.1m
Net result
-€17,738▲ 43.4%
2024 · -€31,336
Working capital
-€42,284▼ 137%
2024 · -€17,839
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20242025
Operating result-€15,810-€19,982
Net result-€31,336--€17,738▲ 43.4%
Equity-€30,836--€48,573▼ 57.5%
Total assets€1.1m-€1.1m▲ 0.2%
Debt€1.1m-€1.1m▲ 1.8%
Working capital-€17,839--€42,284▼ 137%
Staff (FTE)0.4-1▲ 150%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2025: €19,982 after a loss of €15,810 in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.1m
Fixed assets
€1.1m ▼ 0.1%
Current assets
€14,105 ▲ 20.9%
Key figures and ratios
EBITDA
€73,086▲
2024 · €8,880
Cash flow
€35,366▲
2024 · -€6,646
Solvency
-4.5%▼
2024 · -2.9%
Current ratio
0.25▼
2024 · 0.40
Debt to equity
-23.24▲
2024 · -35.98
ROA
-1.6%▲
2024 · -2.9%
Interest coverage
1.96▲
2024 · 0.58
Debt ≤ 1 year
€56,389▲
2024 · €29,505
Debt > 1 year
€1.1m▼
2024 · €1.1m
Income taxes
€361▲
2024 · €187
Staff costs
€11,941▲
2024 · €5,633
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Remuneration, social security and pensions62 | €5,633 | €11,941 | ▲ 112% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €24,690 | €53,104 | ▲ 115% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | €34,468 | - | - |
| Other operating charges640/8 | €50 | €3,531 | ▲ 6,961% |
| Gross operating margin9900 | €49,030 | €88,558 | ▲ 80.6% |
| Operating profit (loss)9901 | -€15,810 | €19,982 | ▲ 226% |
| Financial charges65/66B | €15,339 | €37,359 | ▲ 144% |
| Recurring financial charges65 | €15,339 | €37,359 | ▲ 144% |
| Profit (loss) for the period before taxes9903 | -€31,149 | -€17,377 | ▲ 44.2% |
| Income taxes67/77 | €187 | €361 | ▲ 93.3% |
| Profit (loss) for the period9904 | -€31,336 | -€17,738 | ▲ 43.4% |
| Profit (loss) for the period to be appropriated9905 | -€31,336 | -€17,738 | ▲ 43.4% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €1.1m | €1.1m | ▲ 0.2% |
| Fixed assets21/28 | €1.1m | €1.1m | ▼ 0.1% |
| Tangible fixed assets22/27 | €1.1m | €1.1m | ▼ 0.1% |
| Land and buildings22 | €1.0m | €1.0m | ▲ 0.7% |
| Furniture and vehicles24 | €41,425 | €33,251 | ▼ 19.7% |
| Current assets29/58 | €11,667 | €14,105 | ▲ 20.9% |
| Amounts receivable within one year40/41 | €605 | - | - |
| Trade receivables40 | €605 | - | - |
| Cash at bank and in hand54/58 | €8,454 | €6,914 | ▼ 18.2% |
| Deferred charges and accrued income490/1 | €2,607 | €7,192 | ▲ 176% |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €1.1m | €1.1m | ▲ 0.2% |
| Equity10/15 | -€30,836 | -€48,573 | ▼ 57.5% |
| Contributions10/11 | €500 | €500 | = |
| Profit (loss) carried forward14 | -€31,336 | -€49,073 | ▼ 56.6% |
| Amounts payable17/49 | €1.1m | €1.1m | ▲ 1.8% |
| Amounts payable after more than one year17 | €1.1m | €1.1m | ▼ 0.3% |
| Financial debts170/4 | €1.1m | €1.1m | ▼ 0.3% |
| Amounts payable within one year42/48 | €29,505 | €56,389 | ▲ 91.1% |
| Current portion of amounts payable after more than one year42 | €14,997 | €41,915 | ▲ 179% |
| Trade debts44 | €2,777 | €8,131 | ▲ 193% |
| Suppliers440/4 | €2,777 | €8,131 | ▲ 193% |
| Taxes, remuneration and social security45 | €187 | €1,585 | ▲ 749% |
| Taxes450/3 | €187 | €361 | ▲ 93.3% |
| Remuneration and social security454/9 | - | €1,224 | - |
| Other amounts payable47/48 | €11,544 | €4,759 | ▼ 58.8% |
| Accrued charges and deferred income492/3 | €4,328 | €172 | ▼ 96.0% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | -€31,336 | -€17,738 | ▲ 43.4% |
| + Depreciation and write-downs630 | €24,690 | €53,104 | ▲ 115% |
| Operating cash flow (approximation) | -€6,646 | €35,366 | ▲ 632% |
| Investment in fixed assets (approximation) | - | -€52,374 | - |
| Change in cash | - | -€1,541 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
07-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
NBB filing
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wavre · 1 establishment unit since 2024
Ground area
1.8 ha
Building footprint
693 m²
Volume, LiDAR
1,296 m³
2 parcels, Wallonia · tallest building 7.9 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
MEDISCRIPTA
since 20242.357.532.144
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25772H0022/00V000 | Wallonia | 1.0 ha | 1 · 308 m² | 7.9 m · 1 fl. |
| 25006B0276/00F002 | Wallonia | 7,469 m² | 1 · 385 m² | - |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector and region
2B CLINIC
BE 0881.533.723
Wavre
ANNE TAETER EXPERTISES ET STOMATOLOGIE
BE 0824.855.237
Wavre
BELCARDIO
BE 0792.348.260
Wavre
BS Medical
BE 0680.997.606
Wavre
Cabinet de Gériatrie Alain Fournier
BE 0812.390.341
Wavre
This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of 16,630 companies in sector 86220 we hold annual accounts for 7,981. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded17-03-2024
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
82990Other business support services
Scores and ratios are computed by Checked and are not a credit decision.